16 Overall survival showed a positive trend for the catumaxomab group, and in a prospectively planned analysis it was significantly prolonged in patients with gastric cancer.
← all excerpts
EpCAM expression in primary tumour tissues and metastases: an immunohistochemical analysis.
1
—
—